Highlights

array(40) {
  [0]=>
  string(4) "9418"
  ["article_id"]=>
  string(4) "9418"
  [1]=>
  string(60) "Boosting pharma security: Systech's track and trace tech"
  ["article_title"]=>
  string(60) "Boosting pharma security: Systech's track and trace tech"
  [2]=>
  string(127) "In the fight against counterfeit pharmaceuticals, Systech stands at the forefront with its advanced track and trace technology."
  ["short_description"]=>
  string(127) "In the fight against counterfeit pharmaceuticals, Systech stands at the forefront with its advanced track and trace technology."
  [3]=>
  string(127) "In the fight against counterfeit pharmaceuticals, Systech stands at the forefront with its advanced track and trace technology."
  ["description"]=>
  string(127) "In the fight against counterfeit pharmaceuticals, Systech stands at the forefront with its advanced track and trace technology."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(164) "https://www.outsourcing-pharma.com/Article/2024/08/14/how-systech-secures-pharma-supply-chains-from-counterfeits?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(164) "https://www.outsourcing-pharma.com/Article/2024/08/14/how-systech-secures-pharma-supply-chains-from-counterfeits?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-08-14 19:00:00"
  ["add_date"]=>
  string(19) "2024-08-14 19:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:39"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Boosting pharma security: Systech's track and trace tech

In the fight against counterfeit pharmaceuticals, Systech stands at the forefront with its advanced track and trace tech

array(40) {
  [0]=>
  string(4) "9419"
  ["article_id"]=>
  string(4) "9419"
  [1]=>
  string(75) "How nuVizz transforms pharma supply chains: Insights from its CEO, Guru Rao"
  ["article_title"]=>
  string(75) "How nuVizz transforms pharma supply chains: Insights from its CEO, Guru Rao"
  [2]=>
  string(150) "In the ever-evolving world of pharmaceutical logistics, nuVizz has emerged as a key player, delivering innovative solutions that streamline the delive"
  ["short_description"]=>
  string(150) "In the ever-evolving world of pharmaceutical logistics, nuVizz has emerged as a key player, delivering innovative solutions that streamline the delive"
  [3]=>
  string(172) "In the ever-evolving world of pharmaceutical logistics, nuVizz has emerged as a key player, delivering innovative solutions that streamline the delivery management process."
  ["description"]=>
  string(172) "In the ever-evolving world of pharmaceutical logistics, nuVizz has emerged as a key player, delivering innovative solutions that streamline the delivery management process."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(164) "https://www.outsourcing-pharma.com/Article/2024/08/14/nuvizz-ceo-on-pharma-supply-chain-solutions-and-innovation?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(164) "https://www.outsourcing-pharma.com/Article/2024/08/14/nuvizz-ceo-on-pharma-supply-chain-solutions-and-innovation?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-08-14 19:00:00"
  ["add_date"]=>
  string(19) "2024-08-14 19:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:39"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

How nuVizz transforms pharma supply chains: Insights from its CEO, Guru Rao

In the ever-evolving world of pharmaceutical logistics, nuVizz has emerged as a key player, delivering innovative soluti

array(40) {
  [0]=>
  string(4) "9420"
  ["article_id"]=>
  string(4) "9420"
  [1]=>
  string(89) "Certa’s CEO Jag Lamba on enhancing pharma supply chain traceability and compliance"
  ["article_title"]=>
  string(89) "Certa’s CEO Jag Lamba on enhancing pharma supply chain traceability and compliance"
  [2]=>
  string(150) "In an increasingly complex regulatory landscape, pharmaceutical companies face significant challenges in maintaining transparency and accountability a"
  ["short_description"]=>
  string(150) "In an increasingly complex regulatory landscape, pharmaceutical companies face significant challenges in maintaining transparency and accountability a"
  [3]=>
  string(183) "In an increasingly complex regulatory landscape, pharmaceutical companies face significant challenges in maintaining transparency and accountability across their global supply chains."
  ["description"]=>
  string(183) "In an increasingly complex regulatory landscape, pharmaceutical companies face significant challenges in maintaining transparency and accountability across their global supply chains."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(172) "https://www.outsourcing-pharma.com/Article/2024/08/14/boosting-pharma-supply-chains-certa-on-compliance-and-transparency?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(172) "https://www.outsourcing-pharma.com/Article/2024/08/14/boosting-pharma-supply-chains-certa-on-compliance-and-transparency?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-08-14 19:00:00"
  ["add_date"]=>
  string(19) "2024-08-14 19:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:39"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Certa’s CEO Jag Lamba on enhancing pharma supply chain traceability and compliance

In an increasingly complex regulatory landscape, pharmaceutical companies face significant challenges in maintaining tra

array(40) {
  [0]=>
  string(4) "9421"
  ["article_id"]=>
  string(4) "9421"
  [1]=>
  string(91) "TraceLink and Tecsys partnership: healthcare supply chain with integrated digital solutions"
  ["article_title"]=>
  string(91) "TraceLink and Tecsys partnership: healthcare supply chain with integrated digital solutions"
  [2]=>
  string(150) "In a strategic move aimed at transforming healthcare supply chains, TraceLink, a leading provider of digital supply chain solutions, has partnered wit"
  ["short_description"]=>
  string(150) "In a strategic move aimed at transforming healthcare supply chains, TraceLink, a leading provider of digital supply chain solutions, has partnered wit"
  [3]=>
  string(225) "In a strategic move aimed at transforming healthcare supply chains, TraceLink, a leading provider of digital supply chain solutions, has partnered with Tecsys, an industry leader in inventory and warehouse management systems."
  ["description"]=>
  string(225) "In a strategic move aimed at transforming healthcare supply chains, TraceLink, a leading provider of digital supply chain solutions, has partnered with Tecsys, an industry leader in inventory and warehouse management systems."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(174) "https://www.outsourcing-pharma.com/Article/2024/08/14/streamlining-healthcare-supply-chains-tracelink-teams-up-with-tecsys?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(174) "https://www.outsourcing-pharma.com/Article/2024/08/14/streamlining-healthcare-supply-chains-tracelink-teams-up-with-tecsys?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-08-14 19:00:00"
  ["add_date"]=>
  string(19) "2024-08-14 19:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:40"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

TraceLink and Tecsys partnership: healthcare supply chain with integrated digital solution

In a strategic move aimed at transforming healthcare supply chains, TraceLink, a leading provider of digital supply chai

array(40) {
  [0]=>
  string(4) "9532"
  ["article_id"]=>
  string(4) "9532"
  [1]=>
  string(100) "Halda Therapeutics raises $126M to take 'hold and kill' precision cancer drugs to the clinic"
  ["article_title"]=>
  string(100) "Halda Therapeutics raises $126M to take 'hold and kill' precision cancer drugs to the clinic"
  [2]=>
  string(150) "The investment round will fund the first clinical trials for an innovative therapeutic modality designed to overcome drug resistance in patients with "
  ["short_description"]=>
  string(150) "The investment round will fund the first clinical trials for an innovative therapeutic modality designed to overcome drug resistance in patients with "
  [3]=>
  string(163) "The investment round will fund the first clinical trials for an innovative therapeutic modality designed to overcome drug resistance in patients with solid tumors."
  ["description"]=>
  string(163) "The investment round will fund the first clinical trials for an innovative therapeutic modality designed to overcome drug resistance in patients with solid tumors."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(164) "https://www.biopharma-reporter.com/Article/2024/08/14/halda-therapeutics-secures-126m-for-precision-cancer-drugs?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(164) "https://www.biopharma-reporter.com/Article/2024/08/14/halda-therapeutics-secures-126m-for-precision-cancer-drugs?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-08-14 19:00:00"
  ["add_date"]=>
  string(19) "2024-08-14 19:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:26:38"
  ["create_at"]=>
  string(19) "2024-08-24 15:26:38"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Halda Therapeutics raises $126M to take 'hold and kill' precision cancer drugs to

The investment round will fund the first clinical trials for an innovative therapeutic modality designed to overcome dru

array(40) {
  [0]=>
  string(4) "9417"
  ["article_id"]=>
  string(4) "9417"
  [1]=>
  string(88) "Improving clinical supply chains: An in-depth conversation with IQVIA's Stefan Duerr"
  ["article_title"]=>
  string(88) "Improving clinical supply chains: An in-depth conversation with IQVIA's Stefan Duerr"
  [2]=>
  string(111) "In the intricate world of clinical trials, the integrity and efficiency of the drug supply chain are paramount."
  ["short_description"]=>
  string(111) "In the intricate world of clinical trials, the integrity and efficiency of the drug supply chain are paramount."
  [3]=>
  string(111) "In the intricate world of clinical trials, the integrity and efficiency of the drug supply chain are paramount."
  ["description"]=>
  string(111) "In the intricate world of clinical trials, the integrity and efficiency of the drug supply chain are paramount."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(167) "https://www.outsourcing-pharma.com/Article/2024/08/14/inside-iqvia-s-innovative-drug-supply-chain-with-stefan-duerr?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(167) "https://www.outsourcing-pharma.com/Article/2024/08/14/inside-iqvia-s-innovative-drug-supply-chain-with-stefan-duerr?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-08-14 18:58:00"
  ["add_date"]=>
  string(19) "2024-08-14 18:58:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:39"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Improving clinical supply chains: An in-depth conversation with IQVIA's Stefan Duerr

In the intricate world of clinical trials, the integrity and efficiency of the drug supply chain are paramount.

array(40) {
  [0]=>
  string(4) "9453"
  ["article_id"]=>
  string(4) "9453"
  [1]=>
  string(39) "Getting beyond nurses' fears of AI "
  ["article_title"]=>
  string(39) "Getting beyond nurses' fears of AI "
  [2]=>
  string(150) "Healthcare leaders should address the stress of AI and share roadmaps to gain buy-in from nurses, says Dr. Iman Abuzeid, CEO and cofounder of Incredib"
  ["short_description"]=>
  string(150) "Healthcare leaders should address the stress of AI and share roadmaps to gain buy-in from nurses, says Dr. Iman Abuzeid, CEO and cofounder of Incredib"
  [3]=>
  string(164) "Healthcare leaders should address the stress of AI and share roadmaps to gain buy-in from nurses, says Dr. Iman Abuzeid, CEO and cofounder of Incredible Health.&#nl"
  ["description"]=>
  string(164) "Healthcare leaders should address the stress of AI and share roadmaps to gain buy-in from nurses, says Dr. Iman Abuzeid, CEO and cofounder of Incredible Health.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(68) "https://www.healthcareitnews.com/news/getting-beyond-nurses-fears-ai"
  ["blog_url"]=>
  string(68) "https://www.healthcareitnews.com/news/getting-beyond-nurses-fears-ai"
  [15]=>
  string(19) "2024-08-14 01:08:16"
  ["add_date"]=>
  string(19) "2024-08-14 01:08:16"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:44"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Getting beyond nurses' fears of AI

Healthcare leaders should address the stress of AI and share roadmaps to gain buy-in from nurses, says Dr. Iman Abuzeid,

array(40) {
  [0]=>
  string(4) "9454"
  ["article_id"]=>
  string(4) "9454"
  [1]=>
  string(79) "Proposed new Medicare billing codes could boost digital mental health treatment"
  ["article_title"]=>
  string(79) "Proposed new Medicare billing codes could boost digital mental health treatment"
  [2]=>
  string(154) ""Medicare is a trend setter. By legitimizing these treatments within the Medicare system, it sets a precedent for other insurers to follow suit, poten"
  ["short_description"]=>
  string(154) ""Medicare is a trend setter. By legitimizing these treatments within the Medicare system, it sets a precedent for other insurers to follow suit, poten"
  [3]=>
  string(267) ""Medicare is a trend setter. By legitimizing these treatments within the Medicare system, it sets a precedent for other insurers to follow suit, potentially transforming the landscape of mental healthcare delivery," Digital Therapeutics Alliance CEO says.&#nl"
  ["description"]=>
  string(267) ""Medicare is a trend setter. By legitimizing these treatments within the Medicare system, it sets a precedent for other insurers to follow suit, potentially transforming the landscape of mental healthcare delivery," Digital Therapeutics Alliance CEO says.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(117) "https://www.healthcareitnews.com/news/proposed-new-medicare-billing-codes-could-boost-digital-mental-health-treatment"
  ["blog_url"]=>
  string(117) "https://www.healthcareitnews.com/news/proposed-new-medicare-billing-codes-could-boost-digital-mental-health-treatment"
  [15]=>
  string(19) "2024-08-13 23:02:28"
  ["add_date"]=>
  string(19) "2024-08-13 23:02:28"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:44"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Proposed new Medicare billing codes could boost digital mental health treatment

"Medicare is a trend setter. By legitimizing these treatments within the Medicare system, it sets a precedent for ot

array(40) {
  [0]=>
  string(4) "9455"
  ["article_id"]=>
  string(4) "9455"
  [1]=>
  string(62) "LOINC 2.78 includes 3,000 terminology updates, adds SDOH focus"
  ["article_title"]=>
  string(62) "LOINC 2.78 includes 3,000 terminology updates, adds SDOH focus"
  [2]=>
  string(150) "The update covers a range of healthcare focus areas, including diagnostics, medical devices, public health reporting, social determinants of health an"
  ["short_description"]=>
  string(150) "The update covers a range of healthcare focus areas, including diagnostics, medical devices, public health reporting, social determinants of health an"
  [3]=>
  string(176) "The update covers a range of healthcare focus areas, including diagnostics, medical devices, public health reporting, social determinants of health and various assessments.&#nl"
  ["description"]=>
  string(176) "The update covers a range of healthcare focus areas, including diagnostics, medical devices, public health reporting, social determinants of health and various assessments.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(97) "https://www.healthcareitnews.com/news/loinc-278-includes-3000-terminology-updates-adds-sdoh-focus"
  ["blog_url"]=>
  string(97) "https://www.healthcareitnews.com/news/loinc-278-includes-3000-terminology-updates-adds-sdoh-focus"
  [15]=>
  string(19) "2024-08-13 22:53:58"
  ["add_date"]=>
  string(19) "2024-08-13 22:53:58"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:44"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

LOINC 2.78 includes 3,000 terminology updates, adds SDOH focus

The update covers a range of healthcare focus areas, including diagnostics, medical devices, public health reporting, so

array(40) {
  [0]=>
  string(4) "9399"
  ["article_id"]=>
  string(4) "9399"
  [1]=>
  string(40) "Q&A: SABIC's medical grade PBT resin"
  ["article_title"]=>
  string(40) "Q&A: SABIC's medical grade PBT resin"
  [2]=>
  string(95) "Medical Plastics News talks to SABIC after the introduction of the new medical grade PBT resin."
  ["short_description"]=>
  string(95) "Medical Plastics News talks to SABIC after the introduction of the new medical grade PBT resin."
  [3]=>
  string(95) "Medical Plastics News talks to SABIC after the introduction of the new medical grade PBT resin."
  ["description"]=>
  string(95) "Medical Plastics News talks to SABIC after the introduction of the new medical grade PBT resin."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(106) "https://www.medicalplasticsnews.com/news/latest-medical-plastics-news/q-a-sabic-s-medical-grade-pbt-resin/"
  ["blog_url"]=>
  string(106) "https://www.medicalplasticsnews.com/news/latest-medical-plastics-news/q-a-sabic-s-medical-grade-pbt-resin/"
  [15]=>
  string(19) "2024-08-13 22:30:00"
  ["add_date"]=>
  string(19) "2024-08-13 22:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:32"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Q&A: SABIC's medical grade PBT resin

Medical Plastics News talks to SABIC after the introduction of the new medical grade PBT resin.

array(40) {
  [0]=>
  string(4) "9533"
  ["article_id"]=>
  string(4) "9533"
  [1]=>
  string(81) "Citius Pharma receives FDA approval for immunotherapy targeting rare blood cancer"
  ["article_title"]=>
  string(81) "Citius Pharma receives FDA approval for immunotherapy targeting rare blood cancer"
  [2]=>
  string(150) "The FDA has given the green light to Lymphir, the first immunotherapy for the treatment of cutaneous T-cell lymphoma (CTCL) to get approval in over fi"
  ["short_description"]=>
  string(150) "The FDA has given the green light to Lymphir, the first immunotherapy for the treatment of cutaneous T-cell lymphoma (CTCL) to get approval in over fi"
  [3]=>
  string(159) "The FDA has given the green light to Lymphir, the first immunotherapy for the treatment of cutaneous T-cell lymphoma (CTCL) to get approval in over five years."
  ["description"]=>
  string(159) "The FDA has given the green light to Lymphir, the first immunotherapy for the treatment of cutaneous T-cell lymphoma (CTCL) to get approval in over five years."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(163) "https://www.biopharma-reporter.com/Article/2024/08/13/fda-greenlights-immunotherapy-targeting-rare-blood-cancer?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(163) "https://www.biopharma-reporter.com/Article/2024/08/13/fda-greenlights-immunotherapy-targeting-rare-blood-cancer?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-08-13 21:45:00"
  ["add_date"]=>
  string(19) "2024-08-13 21:45:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:26:38"
  ["create_at"]=>
  string(19) "2024-08-24 15:26:38"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Citius Pharma receives FDA approval for immunotherapy targeting rare blood cancer

The FDA has given the green light to Lymphir, the first immunotherapy for the treatment of cutaneous T-cell lymphoma (CT

array(40) {
  [0]=>
  string(4) "9423"
  ["article_id"]=>
  string(4) "9423"
  [1]=>
  string(74) "Revolutionizing partner evaluations in pharma outsourcing: expert insights"
  ["article_title"]=>
  string(74) "Revolutionizing partner evaluations in pharma outsourcing: expert insights"
  [2]=>
  string(150) "In the rapidly evolving pharmaceutical industry, the process of evaluating outsourcing partners is critical to ensuring quality, efficiency, and innov"
  ["short_description"]=>
  string(150) "In the rapidly evolving pharmaceutical industry, the process of evaluating outsourcing partners is critical to ensuring quality, efficiency, and innov"
  [3]=>
  string(156) "In the rapidly evolving pharmaceutical industry, the process of evaluating outsourcing partners is critical to ensuring quality, efficiency, and innovation."
  ["description"]=>
  string(156) "In the rapidly evolving pharmaceutical industry, the process of evaluating outsourcing partners is critical to ensuring quality, efficiency, and innovation."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(159) "https://www.outsourcing-pharma.com/Article/2024/08/13/expert-insights-on-pharma-outsourcing-with-cluepoints?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(159) "https://www.outsourcing-pharma.com/Article/2024/08/13/expert-insights-on-pharma-outsourcing-with-cluepoints?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-08-13 19:16:00"
  ["add_date"]=>
  string(19) "2024-08-13 19:16:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-08-24 15:24:40"
  ["create_at"]=>
  string(19) "2024-08-24 15:24:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Revolutionizing partner evaluations in pharma outsourcing: expert insights

In the rapidly evolving pharmaceutical industry, the process of evaluating outsourcing partners is critical to ensuring